These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1799186

  • 1. Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis.
    Yoshida A, Morozumi K, Suganuma T, Sugito K, Ikeda M, Oikawa T, Fujinami T, Takeda A, Koyama K.
    Am J Nephrol; 1991; 11(4):284-8. PubMed ID: 1799186
    [Abstract] [Full Text] [Related]

  • 2. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M, Nomura H, Iwainaka Y, Nakashima A, Koni I, Tofuku Y, Takeda R.
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [Abstract] [Full Text] [Related]

  • 3. [Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy].
    Kikuchi M, Saeki T, Ito S, In H, Saito T, Ueno M, Sato T, Suzuki S, Nakano M, Ozawa T.
    Ryumachi; 1993 Jun; 33(3):215-22. PubMed ID: 8346463
    [Abstract] [Full Text] [Related]

  • 4. Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and review of the literature.
    Isozaki T, Kimura M, Ikegaya N, Arai T, Fujigaki Y, Hishida A, Kaneko E.
    Clin Investig; 1992 Nov; 70(11):1036-42. PubMed ID: 1472834
    [Abstract] [Full Text] [Related]

  • 5. Bucillamine induces membranous glomerulonephritis.
    Nagahama K, Matsushita H, Hara M, Ubara Y, Hara S, Yamada A.
    Am J Kidney Dis; 2002 Apr; 39(4):706-12. PubMed ID: 11920335
    [Abstract] [Full Text] [Related]

  • 6. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
    Obayashi M, Uzu T, Harada T, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
    [Abstract] [Full Text] [Related]

  • 7. [Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis].
    Baba N, Nomura T, Sakemi T, Uchida M, Watanabe T.
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):629-34. PubMed ID: 1920943
    [Abstract] [Full Text] [Related]

  • 8. Membranous glomerulonephritis in patients with rheumatoid arthritis.
    Yoshida A, Morozumi K, Takeda A, Koyama K, Oikawa T.
    Clin Ther; 1994 Jun; 16(6):1000-6. PubMed ID: 7697679
    [Abstract] [Full Text] [Related]

  • 9. A case of rapidly progressive glomerulonephritis associated with bucillamine-treated rheumatoid arthritis.
    Yoshida A, Morozumi K, Takeda A, Koyama K, Oikawa T, Fujinami T.
    Am J Kidney Dis; 1992 Oct; 20(4):411-3. PubMed ID: 1415212
    [No Abstract] [Full Text] [Related]

  • 10. [A case of progressive systemic sclerosis with Sjögren's syndrome complicated by nephrotic syndrome caused by bucillamine].
    Ogawa N, Itoh M, Sudo Y, Endo S, Ohashi H, Okugawa T, Furuya R, Hishida A.
    Ryumachi; 1990 Oct; 30(5):362-6, 308; discussion 366-8. PubMed ID: 2084858
    [Abstract] [Full Text] [Related]

  • 11. Outcome and treatment of bucillamine-induced nephropathy.
    Hoshino J, Ubara Y, Hara S, Suwabe T, Sawa N, Tagami T, Katori H, Takemoto F, Hara S, Takaichi K.
    Nephron Clin Pract; 2006 Oct; 104(1):c15-9. PubMed ID: 16685139
    [Abstract] [Full Text] [Related]

  • 12. Bucillamine-induced nephropathy in a child with juvenile rheumatoid arthritis and Kartagener's syndrome.
    Kawasaki Y, Suzuki J, Sike T, Isome M, Nozawa R, Suzuki S, Suyama K, Suzuki H.
    Pediatr Int; 2000 Jun; 42(3):316-8. PubMed ID: 10881595
    [No Abstract] [Full Text] [Related]

  • 13. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
    Matsuno H, Kitano T, Matsushita I, Tsuji H, Ochiai H.
    Drugs Exp Clin Res; 1993 Jun; 19(5):205-11. PubMed ID: 8174492
    [Abstract] [Full Text] [Related]

  • 14. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y, Sagawa A, Atsumi T, Jodo S, Nakabayashi T, Watanabe I, Mukai M, Fujisaku A, Nakagawa S, Kobayashi H.
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [Abstract] [Full Text] [Related]

  • 15. [A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine].
    Matsushima H, Takayanagi N, Sakamoto T, Motegi M, Ubukata M, Yanagisawa T, Sugita Y, Kanazawa M, Kawabata Y.
    Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):55-9. PubMed ID: 11296388
    [Abstract] [Full Text] [Related]

  • 16. [Drug induced nephrotic syndrome].
    Ohno I.
    Nihon Rinsho; 2004 Oct; 62(10):1919-24. PubMed ID: 15500140
    [Abstract] [Full Text] [Related]

  • 17. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
    Yoshida A, Morozumi K, Suganuma T, Aoki J, Sugito K, Koyama K, Oikawa T, Fujinimi T, Matsumoto Y.
    Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
    [Abstract] [Full Text] [Related]

  • 18. Hyperplasia of Lymphoid Follicles and Lymphangiectasia in the Parietal Pleura in Bucillamine-induced Yellow Nail Syndrome.
    Hase I, Kurasawa K, Takizawa H, Yamaguchi B, Sakuma H, Ishii Y.
    Intern Med; 2018 Jul 01; 57(13):1887-1892. PubMed ID: 29434155
    [Abstract] [Full Text] [Related]

  • 19. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis].
    Kishimoto N, Fujii K.
    Nihon Kokyuki Gakkai Zasshi; 2002 Apr 01; 40(4):321-5. PubMed ID: 12096503
    [Abstract] [Full Text] [Related]

  • 20. Membranous nephropathy caused by rheumatoid arthritis.
    Iida A, Wada Y, Hayashi J, Tachibana S, Inaba T, Iyoda M, Honda K, Shibata T.
    CEN Case Rep; 2019 Nov 01; 8(4):233-238. PubMed ID: 31037495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.